Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C₄₄Mab-34, for Multiple Applications against Oral Carcinomas

Cluster of differentiation 44 (CD44) has been investigated as a cancer stem cell (CSC) marker as it plays critical roles in tumor malignant progression. The splicing variants are overexpressed in many carcinomas, especially squamous cell carcinomas, and play critical roles in the promotion of tumor...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Hiroyuki Suzuki, Kazuki Ozawa, Tomohiro Tanaka, Mika K. Kaneko, Yukinari Kato
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2023-04-01
Sarja:	Biomedicines
Aiheet:	CD44 CD44 variant 7/8 monoclonal antibody flow cytometry immunohistochemistry
Linkit:	https://www.mdpi.com/2227-9059/11/4/1099
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!